Zhang Z, Ding B, He H, Wang J, Liu X, Guo J
Vet World. 2022; 15(4):911-918.
PMID: 35698512
PMC: 9178600.
DOI: 10.14202/vetworld.2022.911-918.
Li H, Herrmann T, Seessle J, Liebisch G, Merle U, Stremmel W
Biosci Rep. 2022; 42(6).
PMID: 35583196
PMC: 9160530.
DOI: 10.1042/BSR20211854.
Gawdzik B, Kowalczyk P, Koszelewski D, Brodzka A, Masternak J, Kramkowski K
Membranes (Basel). 2022; 12(2).
PMID: 35207159
PMC: 8878598.
DOI: 10.3390/membranes12020238.
Ma Y, Nenkov M, Chen Y, Press A, Kaemmerer E, Gassler N
World J Hepatol. 2021; 13(11):1512-1533.
PMID: 34904027
PMC: 8637682.
DOI: 10.4254/wjh.v13.i11.1512.
Jeong H, Oh H, Kim H, Lee J, Lee E, Kim Y
Pathol Oncol Res. 2021; 27:594705.
PMID: 34257543
PMC: 8262182.
DOI: 10.3389/pore.2021.594705.
Intestinal Saturated Long-Chain Fatty Acid, Glucose and Fructose Transporters and Their Inhibition by Natural Plant Extracts in Caco-2 Cells.
Schreck K, Melzig M
Molecules. 2018; 23(10).
PMID: 30301205
PMC: 6222386.
DOI: 10.3390/molecules23102544.
Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.
Black P, Ahowesso C, Montefusco D, Saini N, DiRusso C
Medchemcomm. 2016; 7(4):612-622.
PMID: 27446528
PMC: 4948302.
DOI: 10.1039/C6MD00043F.
Targeting the fatty acid transport proteins (FATP) to understand the mechanisms linking fatty acid transport to metabolism.
Black P, Sandoval A, Arias-Barrau E, DiRusso C
Immunol Endocr Metab Agents Med Chem. 2015; 9(1):11-17.
PMID: 26635907
PMC: 4665979.
DOI: 10.2174/187152209788009850.
Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death.
Ahowesso C, Black P, Saini N, Montefusco D, Chekal J, Malosh C
Biochem Pharmacol. 2015; 98(1):167-81.
PMID: 26394026
PMC: 4610366.
DOI: 10.1016/j.bcp.2015.09.004.
Measurement of long-chain fatty acid uptake into adipocytes.
Dubikovskaya E, Chudnovskiy R, Karateev G, Park H, Stahl A
Methods Enzymol. 2014; 538:107-34.
PMID: 24529436
PMC: 4269161.
DOI: 10.1016/B978-0-12-800280-3.00007-4.
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, Spedding M
Br J Pharmacol. 2014; 170(8):1706-96.
PMID: 24528242
PMC: 3892292.
DOI: 10.1111/bph.12450.
SLC27 fatty acid transport proteins.
Anderson C, Stahl A
Mol Aspects Med. 2013; 34(2-3):516-28.
PMID: 23506886
PMC: 3602789.
DOI: 10.1016/j.mam.2012.07.010.
Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells.
Krammer J, Digel M, Ehehalt F, Stremmel W, Fullekrug J, Ehehalt R
Int J Med Sci. 2011; 8(7):599-614.
PMID: 22022213
PMC: 3198256.
DOI: 10.7150/ijms.8.599.
Gut triglyceride production.
Pan X, Hussain M
Biochim Biophys Acta. 2011; 1821(5):727-35.
PMID: 21989069
PMC: 3319358.
DOI: 10.1016/j.bbalip.2011.09.013.
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
Falcon A, Doege H, Fluitt A, Tsang B, Watson N, Kay M
Am J Physiol Endocrinol Metab. 2010; 299(3):E384-93.
PMID: 20530735
PMC: 2944282.
DOI: 10.1152/ajpendo.00226.2010.
Development and validation of a high-throughput screening assay for human long-chain fatty acid transport proteins 4 and 5.
Zhou W, Madrid P, Fluitt A, Stahl A, Xie X
J Biomol Screen. 2010; 15(5):488-97.
PMID: 20448275
PMC: 2887688.
DOI: 10.1177/1087057110369700.
Long-chain acyl-CoA synthetases and fatty acid channeling.
Mashek D, Li L, Coleman R
Future Lipidol. 2011; 2(4):465-476.
PMID: 20354580
PMC: 2846691.
DOI: 10.2217/17460875.2.4.465.
Identification and characterization of small compound inhibitors of human FATP2.
Sandoval A, Chokshi A, Jesch E, Black P, DiRusso C
Biochem Pharmacol. 2009; 79(7):990-9.
PMID: 19913517
PMC: 2814954.
DOI: 10.1016/j.bcp.2009.11.008.